PDC 809: Asbestos and Respirable Crystalline Silica Immersive Risk Assessment Experience – NEW!
Thu, 6/4: 8:00 AM - 5:00 PM CDT
P809
Professional Development Courses (PDCs)
P809
Professional Development Courses (PDCs)
Ernest N. Morial New Orleans Convention Center
CM Credit Hours: 7
Description
*Please note: PDCs are at an additional cost, and preregistration is required*
To register, please visit: https://aihaconnect.org/register
Participants will engage in a comprehensive comparative study of two major respiratory toxicants: asbestos and crystalline silica. The course includes an in-depth exploration of the human respiratory system to support understanding of exposure, dose, response and risk.
Key questions addressed include: Why do different particles affect the lungs and pleura differently? Why does asbestos cause mesothelioma while silica does not? How can professionals distinguish between asbestiform and non-asbestiform elongate particles? How can risk for asbestosis and silicosis be predicted in exposed populations? What are the implications for workers exposed to both silica and asbestos?
Participants will gain essential knowledge for performing risk assessments on respiratory toxicants and will be better prepared to conduct similar analyses for other existing and emerging agents.
*Registration includes boxed luncheon. **Power strips will not be provided at each attendee's seat; however, laptop charging stations will be provided in each course room.
To register, please visit: https://aihaconnect.org/register
Participants will engage in a comprehensive comparative study of two major respiratory toxicants: asbestos and crystalline silica. The course includes an in-depth exploration of the human respiratory system to support understanding of exposure, dose, response and risk.
Key questions addressed include: Why do different particles affect the lungs and pleura differently? Why does asbestos cause mesothelioma while silica does not? How can professionals distinguish between asbestiform and non-asbestiform elongate particles? How can risk for asbestosis and silicosis be predicted in exposed populations? What are the implications for workers exposed to both silica and asbestos?
Participants will gain essential knowledge for performing risk assessments on respiratory toxicants and will be better prepared to conduct similar analyses for other existing and emerging agents.
*Registration includes boxed luncheon. **Power strips will not be provided at each attendee's seat; however, laptop charging stations will be provided in each course room.
Course Outline
• Human respiratory system: going down the airstream
• Silica vs. elongate mineral particles: what's common, what's different
• Health outcomes of silica and asbestos: overlap and distinctions
• Asbestosis vs. silicosis: what occupational health professionals should know
• Dose-response for silica and asbestos with a focus on lung cancer outcomes
• Classification of particles: amorphous and crystalline silica; asbestiform and non-asbestiform asbestos
• Case studies on risk assessment: from hazard identification to risk characterization
• Silica vs. elongate mineral particles: what's common, what's different
• Health outcomes of silica and asbestos: overlap and distinctions
• Asbestosis vs. silicosis: what occupational health professionals should know
• Dose-response for silica and asbestos with a focus on lung cancer outcomes
• Classification of particles: amorphous and crystalline silica; asbestiform and non-asbestiform asbestos
• Case studies on risk assessment: from hazard identification to risk characterization
Learning Outcomes
Upon completion, the participant will be able to:
• Describe the structure of the human respiratory system and its relevance to toxicological processes.
• List the typical characteristics of respiratory toxicants.
• Compare elongate mineral particles (asbestos) and crystalline silica to identify differences and similarities in health effects and toxicity.
• Determine appropriate sampling strategies for asbestos and silica.
• Utilize current assessment tools to evaluate risks for asbestosis, silicosis and lung cancer.
• Classify elongate mineral particles as asbestiform or non-asbestiform, and silica as amorphous or crystalline.
• Distinguish between acceptable and unacceptable levels of risk.
• Communicate asbestos and silica risks to workers and communities.
• Describe the structure of the human respiratory system and its relevance to toxicological processes.
• List the typical characteristics of respiratory toxicants.
• Compare elongate mineral particles (asbestos) and crystalline silica to identify differences and similarities in health effects and toxicity.
• Determine appropriate sampling strategies for asbestos and silica.
• Utilize current assessment tools to evaluate risks for asbestosis, silicosis and lung cancer.
• Classify elongate mineral particles as asbestiform or non-asbestiform, and silica as amorphous or crystalline.
• Distinguish between acceptable and unacceptable levels of risk.
• Communicate asbestos and silica risks to workers and communities.
Prerequisites
Basic knowledge of statistics is recommended.
Value Added
Attendees will receive an Excel-based risk calculator.
Business Case/IH Value Statement
The knowledge gained from this course on risk assessment for asbestos and silica will be immediately applicable to participants' practical activities. It can be used to help reduce risk for workers and communities.
Learning Aids
Laptop
Content Level
Intermediate
Core Competencies
Exposure Assessment
Risk Assessment
Toxicology / Human Disease
Keywords
Aerosol and airborne particulate monitoring
Exposure Assessment
Hazard Communication
Risk assessment and management
Toxicology
Session Availability
In-person
Targeted Audience
Professional
Transfer of Knowledge
Case Studies
Hands-on demonstrations and practicum